Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1989;2(2):96–101. doi: 10.1007/BF02459327

Cytomegalovirus infection in orthotopic liver transplantation

L H Sayage 1, T A Gonwa 2,✉, R M Goldstein 1, B S Husberg 1, G B Klintmalm 1
PMCID: PMC7095869  PMID: 2551315

Abstract

We retrospectively studied 175 orthotopic liver transplants in 151 patients. Of the 151 patients, 59 (39.1%) were diagnosed as having cytomegalovirus (CMV) infection. The rate of infection in patients treated for rejection was 48.8% as compared to 26.2% in patients without rejection (P<0.01). Antirejection therapy was associated with culture-positive cases in 33 out of 43 patients as compared to 9 out of 16 patients who had CMV antibody titer elevations. Patients were treated with gancyclovir if they had simultaneous positive cultures from multiple sites and were seriously ill. Eighteen of the 19 patients thus treated had side effects, one of which was serious (bone marrow hypoplasia). Cultures became negative in 15 out of 17 (88%) of the surviving patients. Patient survival was similar to our overall survival rate of 87%.

Key words: Liver transplantation, and cytomegalovirus infection; Cytomegalovirus infection, in liver transplantation; Gancyclovir, for cytomegalovirus infection, in liver transplantation

References

  • 1.Canadian Multicenter Transplant Study Group A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med. 1983;309:809–815. doi: 10.1056/NEJM198310063091401. [DOI] [PubMed] [Google Scholar]
  • 2.Emanuel D, Cunningham I, Jules-Elysee K, Brochstein JA, Kernan NA, Laver J, Stover D, White DA, Fels A, Polsky B, Castro-Malaspina H, Peppard JR, Bartus P, Hammerling U, O'Reilly RJ. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of gancyclovir and high-dose intravenous immune globulin. Ann Intern Med. 1988;109:777–782. doi: 10.7326/0003-4819-109-10-777. [DOI] [PubMed] [Google Scholar]
  • 3.Erice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HH., Jr Gancyclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. JAMA. 1987;257:3082–3087. doi: 10.1001/jama.257.22.3082. [DOI] [PubMed] [Google Scholar]
  • 4.Fong CK, Cohen SD, McCormick S, Hsiung GD. Antiviral effect of 9-(1,3 dihydroxy-2-propoxymethyl) guanine against cytomegalovirus infection in a guinea pig model. Antiviral Res. 1987;7:11–23. doi: 10.1016/0166-3542(87)90035-0. [DOI] [PubMed] [Google Scholar]
  • 5.Gleaves CA, Smith TF, Shuster EA, Pearson GR. Rapid detection of cytomegalovirus in MRC-5 cells innoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J Clin Microbiol. 1984;19:917–919. doi: 10.1128/jcm.19.6.917-919.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Gleaves CA, Smith TF, Shuster EA, Pearson GR. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol. 1985;21:217–221. doi: 10.1128/jcm.21.2.217-221.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Harbison MA, DeGirolami PC, Jenkins RL, Hammer SM. Gancyclovir therapy of severe cytomegalovirus infections in solid organ transplant recipients. Transplantation. 1988;46:82–88. doi: 10.1097/00007890-198807000-00015. [DOI] [PubMed] [Google Scholar]
  • 8.Icenogle TB, Peterson E, Ray G, Minnich L, Copeland JG. DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report. J Heart Transplant. 1987;4:199–203. [PubMed] [Google Scholar]
  • 9.Krom RA. Liver transplantation at the Mayo Clinic. Mayo Clin Proc. 1986;61:278–282. doi: 10.1016/s0025-6196(12)61930-2. [DOI] [PubMed] [Google Scholar]
  • 10.Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, Tzakis AG, Starzl TE, Monto HO. Infections after liver transplantation — an analysis of 101 consecutive cases. Medicine. 1988;67:132–143. doi: 10.1097/00005792-198803000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lopez C, Simmons RL, Mauer SM, Najarian JS, Good RA. Association of renal allograft rejection with virus infections. Am J Med. 1974;56:280–289. doi: 10.1016/0002-9343(74)90609-3. [DOI] [PubMed] [Google Scholar]
  • 12.Mai ML, Nery JR, Sutker W, Gonwa TA, Husberg BS, Klintmalm GB. DHPG (gancyclovir) improves survival in CMV pneumonia. Transplant Proc. 1989;21:2263–2265. [PubMed] [Google Scholar]
  • 13.Mar EC, Cheng YC, Huang ES. Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on human cytomegalovirus replication in vitro. Antimicrob Agents Chemother. 1983;24:518–521. doi: 10.1128/aac.24.4.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Marker SC, Howard RJ, Simmons RL, Kalis JM, Connelly DP, Najarian JS, Balfour HH., Jr Cytomegalovirus infection: a quantitative prospective study of 320 consecutive renal transplants. Surgery. 1988;89:660–671. [PubMed] [Google Scholar]
  • 15.Peterson PK, Balfour HH, Marker SC. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine. 1980;59:283–300. [PubMed] [Google Scholar]
  • 16.Peterson PK, Ferguson R, Fryd DS, Balfour HH, Jr, Rynaslewicz J, Simmons RL. Infectious diseases in hospitalized renal transplant recipients: a prospective study of a complex and evolving problem. Medicine. 1982;61:360–372. doi: 10.1097/00005792-198211000-00002. [DOI] [PubMed] [Google Scholar]
  • 17.Reed EC, Bowden RA, Dandliker PS, Lilleby KE, Meyers JD. Treatment of cytomegalovirus pneumonia with gancyclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Annals Int Med. 1988;109:783–788. doi: 10.7326/0003-4819-109-10-783. [DOI] [PubMed] [Google Scholar]
  • 18.Schmidt GM, Kovasc A, Zaia JA, Horak DA, Blume KG, Nademanee AP, O'Donnell MR, Synder DS, Forman SJ. Gancyclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allgoraft recipients. Transplantation. 1988;46:905–907. doi: 10.1097/00007890-198812000-00022. [DOI] [PubMed] [Google Scholar]
  • 19.Shuster EA, Beneke JS, Tegtmeler GE, Pearson GR, Gleaves CA, Wold AD, Smith TF. Monoclonal antibody for rapid laboratory detection of cytomegalovirus infections: characterization and diagnostic application. Mayo Clin Proc. 1985;60:577–585. doi: 10.1016/s0025-6196(12)60979-3. [DOI] [PubMed] [Google Scholar]
  • 20.Tocci MJ, Livelli TJ, Perry HC, Crumpacker CS, Field AK. Effects of the nucleoside analogue 2′-nor-2′-deoxyguanosine on human cytomegalovirus replication. Antimicrob Agents Chemother. 1984;25:247–252. doi: 10.1128/aac.25.2.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tyms AS, Davis JM, Jeffries DJ, Meyers JD. BWB759U, an analogue of acyclovir, inhibits human cytomegalovirus in vitro. Lancet. 1984;II:924–925. doi: 10.1016/S0140-6736(84)90677-9. [DOI] [PubMed] [Google Scholar]

Articles from Transplant International are provided here courtesy of Nature Publishing Group

RESOURCES